Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries

Background Biomarkers may enhance diagnostic capability for common paediatric infections, especially in low- and middle-income countries (LMICs) where standard diagnostic modalities are frequently unavailable, but disease burden is high. A comprehensive understanding of the diagnostic capability of...

Full description

Bibliographic Details
Main Authors: Chris A Rees, Jamie Lim, Michelle Niescierenko, Julia Rubin-Smith, Alexis Schmid, Adrianna L Westbrook, Rachelle El Helou, Kyra Shreeve, Chloe Rotman, Sindu Govindapillai, Kate Dorney
Format: Article
Language:English
Published: BMJ Publishing Group 2023-12-01
Series:BMJ Paediatrics Open
Online Access:https://bmjpaedsopen.bmj.com/content/7/1/e001627.full
_version_ 1797367981114654720
author Chris A Rees
Jamie Lim
Michelle Niescierenko
Julia Rubin-Smith
Alexis Schmid
Adrianna L Westbrook
Rachelle El Helou
Kyra Shreeve
Chloe Rotman
Sindu Govindapillai
Kate Dorney
author_facet Chris A Rees
Jamie Lim
Michelle Niescierenko
Julia Rubin-Smith
Alexis Schmid
Adrianna L Westbrook
Rachelle El Helou
Kyra Shreeve
Chloe Rotman
Sindu Govindapillai
Kate Dorney
author_sort Chris A Rees
collection DOAJ
description Background Biomarkers may enhance diagnostic capability for common paediatric infections, especially in low- and middle-income countries (LMICs) where standard diagnostic modalities are frequently unavailable, but disease burden is high. A comprehensive understanding of the diagnostic capability of commonly available biomarkers for neonatal sepsis in LMICs is lacking. Our objective was to systematically review evidence on biomarkers to understand their diagnostic performance for neonatal sepsis in LMICs.Methods We conducted a systematic review and meta-analysis of studies published in English, Spanish, French, German, Dutch, and Arabic reporting the diagnostic performance of C reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cell count (WBC) and procalcitonin (PCT) for neonatal sepsis. We calculated pooled test characteristics and the area under the curve (AUC) for each biomarker compared with the reference standards blood culture or clinical sepsis defined by each article.Results Of 6570 studies related to biomarkers in children, 134 met inclusion criteria and included 23 179 neonates. There were 80 (59.7%) studies conducted in LMICs. CRP of ≥60 mg/L (AUC 0.87, 95% CI 0.76 to 0.91) among 1339 neonates and PCT of ≥0.5 ng/mL (AUC 0.87, 95% CI 0.70 to 0.92) among 617 neonates demonstrated the greatest discriminatory value for the diagnosis of neonatal sepsis using blood culture as the reference standard in LMICs.Conclusions PCT and CRP had good discriminatory value for neonatal sepsis in LMICs. ESR and WBC demonstrated poor discrimination for neonatal sepsis in LMICs. Future studies may incorporate biomarkers into clinical evaluation in LMICs to diagnose neonatal sepsis more accurately.PROSPERO registration number CRD42020188680.
first_indexed 2024-03-08T17:25:56Z
format Article
id doaj.art-b264e92f7caa4005a6f23b44ee1fbd85
institution Directory Open Access Journal
issn 2399-9772
language English
last_indexed 2024-03-08T17:25:56Z
publishDate 2023-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Paediatrics Open
spelling doaj.art-b264e92f7caa4005a6f23b44ee1fbd852024-01-02T20:50:08ZengBMJ Publishing GroupBMJ Paediatrics Open2399-97722023-12-017110.1136/bmjpo-2022-001627Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countriesChris A Rees0Jamie Lim1Michelle Niescierenko2Julia Rubin-Smith3Alexis Schmid4Adrianna L Westbrook5Rachelle El Helou6Kyra Shreeve7Chloe Rotman8Sindu Govindapillai9Kate Dorney10Emergency Medicine, Children`s Healthcare of Atlanta, Atlanta, Georgia, USA3 Advanced Practice NurseDivision of Emergency Medicine, Boston Children s Hospital, Boston, Massachusetts, USAGlobal Health Program, Boston Children`s Hospital, Boston, Massachusetts, USAGlobal Health Program, Boston Children`s Hospital, Boston, Massachusetts, USAPediatric Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, Georgia, USA5 Division of Emergency Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA7 Global Health Program, Boston Children’s Hospital, Boston, Massachusetts, USA8 Medical Library, Boston Children’s Hospital, Boston, Massachusetts, USA9 Department of Pediatrics, Qikiqtani General Hospital, Iqaluit, Nunavut, Canada5 Division of Emergency Medicine, Boston Children’s Hospital, Boston, Massachusetts, USABackground Biomarkers may enhance diagnostic capability for common paediatric infections, especially in low- and middle-income countries (LMICs) where standard diagnostic modalities are frequently unavailable, but disease burden is high. A comprehensive understanding of the diagnostic capability of commonly available biomarkers for neonatal sepsis in LMICs is lacking. Our objective was to systematically review evidence on biomarkers to understand their diagnostic performance for neonatal sepsis in LMICs.Methods We conducted a systematic review and meta-analysis of studies published in English, Spanish, French, German, Dutch, and Arabic reporting the diagnostic performance of C reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cell count (WBC) and procalcitonin (PCT) for neonatal sepsis. We calculated pooled test characteristics and the area under the curve (AUC) for each biomarker compared with the reference standards blood culture or clinical sepsis defined by each article.Results Of 6570 studies related to biomarkers in children, 134 met inclusion criteria and included 23 179 neonates. There were 80 (59.7%) studies conducted in LMICs. CRP of ≥60 mg/L (AUC 0.87, 95% CI 0.76 to 0.91) among 1339 neonates and PCT of ≥0.5 ng/mL (AUC 0.87, 95% CI 0.70 to 0.92) among 617 neonates demonstrated the greatest discriminatory value for the diagnosis of neonatal sepsis using blood culture as the reference standard in LMICs.Conclusions PCT and CRP had good discriminatory value for neonatal sepsis in LMICs. ESR and WBC demonstrated poor discrimination for neonatal sepsis in LMICs. Future studies may incorporate biomarkers into clinical evaluation in LMICs to diagnose neonatal sepsis more accurately.PROSPERO registration number CRD42020188680.https://bmjpaedsopen.bmj.com/content/7/1/e001627.full
spellingShingle Chris A Rees
Jamie Lim
Michelle Niescierenko
Julia Rubin-Smith
Alexis Schmid
Adrianna L Westbrook
Rachelle El Helou
Kyra Shreeve
Chloe Rotman
Sindu Govindapillai
Kate Dorney
Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries
BMJ Paediatrics Open
title Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries
title_full Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries
title_fullStr Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries
title_full_unstemmed Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries
title_short Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries
title_sort systematic review and meta analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low and middle income countries
url https://bmjpaedsopen.bmj.com/content/7/1/e001627.full
work_keys_str_mv AT chrisarees systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT jamielim systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT michelleniescierenko systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT juliarubinsmith systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT alexisschmid systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT adriannalwestbrook systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT rachelleelhelou systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT kyrashreeve systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT chloerotman systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT sindugovindapillai systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries
AT katedorney systematicreviewandmetaanalysisofthediagnosticvalueoffourbiomarkersindetectingneonatalsepsisinlowandmiddleincomecountries